文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

多数据库研究中结局错分定量:ADVANCE项目中的百日咳案例研究

Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project.
PubMed 文献 · Vaccine · 2019-10-31

ADVANCE项目利用欧洲医疗数据库测试疫苗获益-风险监测系统,以百日咳为案例,比较不同病例识别算法的发病率并与ECDC监测数据对标,用新公式近似估计阳性预测值和灵敏度。含特定概念的算法灵敏度低,加入非特定概念会引入假阳性(在一个数据库中约28%),仅住院才能发现的病例占比在一个数据库中约15%。

要点

  • 仅用特定概念检索百日咳病例在初级保健数据库中灵敏度低。
  • 纳入非特定概念会引入假阳性,一个数据库约28%。
  • 仅住院才能发现的病例占比在一个数据库中约15%。

核心结论

  • 仅用特定概念检索百日咳病例在初级保健数据库中灵敏度低,而纳入非特定概念会引入假阳性(一个数据库约28%),仅住院才能发现的病例占比在一个数据库中约15%;跨数据库量化不同事件识别算法的影响并与疾病监测数据对标,可提供算法效度的近似估计。

研究设计与样本

  • ADVANCE为公私合作项目,旨在开发并测试利用欧洲医疗数据库进行疫苗获益-风险快速监测的系统。
  • 四个参与数据库检索初级保健数据:BIFAP(西班牙)、THIN和RCGP RSC(英国)、PEDIANET(意大利);SIDIAP(西班牙)同时检索初级保健和医院数据。
  • 百日咳(BorPer)算法按医疗场所、数据域(诊断、药物或实验室检测)和概念集(特定或非特定百日咳)定义。
  • 在2012年和2014年入组并随访至各日历年年底的0-14岁儿童中估计算法和数据库特异的百日咳发病率,并与ECDC监测系统(TESSy)的确诊百日咳发病率比较。
  • 使用新公式在少量假设基础上近似效度指标,应用于SIDIAP近似估计阳性预测值和灵敏度。

主要发现

  • 初级保健数据中,数据代表3,173,268人-年,BIFAP、SIDIAP、THIN、RCGP RSC和PEDIANET的百日咳病例数分别为0、21、21、79和2,每10万人-年发病率分别为0.0、4.3、5.1、5.7和2.3。
  • 特定/非特定百日咳合并的发病率高于TESSy,提示纳入了一些假阳性。
  • SIDIAP中纳入出院诊断时估计发病率为45.0。
  • SIDIAP中初级保健特定和非特定诊断合并识别百日咳病例的灵敏度和阳性预测值分别约为85%和72%。

关键数值与推荐

  • SIDIAP中初级保健特定和非特定诊断合并识别百日咳病例的灵敏度约85%、阳性预测值约72%。
  • 一个数据库中假阳性约28%,仅住院才能发现的病例占比约15%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is a public-private collaboration aiming to develop and test a system for rapid benefit-risk (B/R) monitoring of vaccines using European healthcare databases. Event misclassification can result in biased estimates. Using different algorithms for identifying cases of Bordetella pertussis (BorPer) infection as a test case, we aimed to describe a strategy to quantify event misclassification, when manual chart review is not feasible. METHODS: Four participating databases retrieved data from primary care (PC) setting: BIFAP: (Spain), THIN and RCGP RSC (UK) and PEDIANET (Italy); SIDIAP (Spain) retrieved data from both PC and hospital settings. BorPer algorithms were defined by healthcare setting, data domain (diagnoses, drugs, or laboratory tests) and concept sets (specific or unspecified pertussis). Algorithm- and database-specific BorPer incidence rates (IRs) were estimated in children aged 0-14 years enrolled in 2012 and 2014 and followed up until the end of each calendar year and compared with IRs of confirmed pertussis from the ECDC surveillance system (TESSy). Novel formulas were used to approximate validity indices, based on a small set of assumptions. They were applied to approximately estimate positive predictive value (PPV) and sensitivity in SIDIAP. RESULTS: The number of cases and the estimated BorPer IRs per 100,000 person-years in PC, using data representing 3,173,268 person-years, were 0 (IR = 0.0), 21 (IR = 4.3), 21 (IR = 5.1), 79 (IR = 5.7), and 2 (IR = 2.3) in BIFAP, SIDIAP, THIN, RCGP RSC and PEDIANET respectively. The IRs for combined specific/unspecified pertussis were higher than TESSy, suggesting that some false positives had been included. In SIDIAP the estimated IR was 45.0 when discharge diagnoses were included. The sensitivity and PPV of combined PC specific and unspecific diagnoses for BorPer cases in SIDIAP were approximately 85% and 72%, respectively. CONCLUSION: Retrieving BorPer cases using only specific concepts has low sensitivity in PC databases, while including cases retrieved by unspecified concepts introduces false positives, which were approximately estimated to be 28% in one database. The share of cases that cannot be retrieved from a PC database because they are only seen in hospital was approximately estimated to be 15% in one database. This study demonstrated that quantifying the impact of different event-finding algorithms across databases and benchmarking with disease surveillance data can provide approximate estimates of algorithm validity.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gini R, Dodd CN, Bollaerts K, et al. Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project. Vaccine. 2019. PMID: 31677950. doi:10.1016/j.vaccine.2019.07.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。